NIH-funded research R21 grant

Improving the recovery of syphilis-causing bacteria's genome

Official title: Sensitive Treponema pallidum genome recovery through tiling amplicon sequencing

Funded at University of Washington · NIH-10975482 · Data updated 2026-11-12

This study is working on a new way to find the DNA of the syphilis-causing bacteria in samples from patients, which will help doctors better understand and respond to syphilis cases around the world.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 5, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$264,750
NIH project number1R21AI185726-01
Project IDNIH-10975482 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with syphilis or those who may have been exposed to the infection.

Less likely to help

Patients who do not have syphilis or are not at risk of exposure to Treponema pallidum may not benefit from this research.

What this research studies

This research focuses on enhancing the methods used to recover the genome of Treponema pallidum, the bacterium responsible for syphilis, from clinical samples. The team will develop a new tiling amplicon sequencing technique that allows for better detection of the bacterium's DNA, which is often present in very low amounts. By optimizing this approach, the researchers aim to improve the accuracy and reliability of genomic epidemiology for syphilis, which is crucial for public health responses. The study will involve testing this method on various clinical specimens collected globally.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and better tracking of syphilis outbreaks, ultimately improving patient care and public health strategies.

How similar studies have gone: Previous research has shown success in genomic recovery techniques for other bacterial pathogens, suggesting potential for this novel approach to yield significant results.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Greninger, Alexander L — University of Washington
  • Study coordinator: Greninger, Alexander L

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.